Isotretinoin ameliorates renal damage in experimental acute renal allograft rejection
Isotretinoin ameliorates renal damage in experimental acute renal allograft rejection
复制标题
DOI:
10.1097/01.tp.0000066354.31050.5a
复制
发表时间:
2003-08-15
期刊:
影响因子:
6.2
通讯作者:
Wagner, J
中科院分区:
文献类型:
--
作者:
Kiss, E;Adams, J;Wagner, J
Background. Retinoic acids, derivatives of vitamin A, act through retinoid receptors that are expressed in renal and immunocompetent cells (B and T cells; monocytes and macrophages). In experimental models of glomerulonephritis and renal interstitial disease, retinoids were shown to reduce both glomerular and tubular damage and inflammation. We therefore examined whether retinoids reduce cellular rejection and renal damage in a model of acute renal allograft rejection.Methods. Kidneys of Fisher rats (F344, RT1(1v1)) were orthotopically grafted to Lewis rats (RT1(1)). Animals were killed 7 or 14 days after transplantation. Rats undergoing transplantation were treated with isotretinoin (13 cis-retinoic acid) at a low dose of 2 mg/kg body weight per day (LD isotretinoin) or at a high dose of 20 mg/kg body weight per day (HD isotretinoin) or with vehicle.Results. At day 14, albuminuria was reduced by approximately 70% (vehicle: 1.1+/-0.2 mg/24 hr vs. LD isotretinoin: 0.32+/-0.1 mg/24 hr; P